Revenue generation: near-term through a limited number of clinics in Europe and through licensing partnerships to 3rd party clinics; medium-term through out-licencing or sale of R&D assets



Develop proprietary therapies to drive R&D and generate real world evidence & revenue for the business.

  • Awakn has 3 clinics operational: London (UK), Bristol (UK), Oslo (Norway)
  • Q4-Q1 21/22 revenue growth 24% QoQ
  • Q1-Q2 2022 revenue growth 34% QoQ
  • Q2-Q3 2022 revenue growth 27% QoQ
  • We provide treatments programs for addiction and mental health conditions such as depression and PTSD
  • An average 6-room clinic can generate up to CA$4.5M per annum

About Awakn Clinics

In our clinics, we deliver Psychedelic-Assisted Therapy as a treatment for mental health and addiction. This approach combines talking therapy with sessions assisted by psychedelics. We currently use Ketamine-Assisted Therapy.

This combination has unique effects on the brain circuitry associated with unhelpful thinking and behavioural patterns. It may allow you to work through issues in ways that have not been possible with therapy alone, and help you to relearn the behaviours and thought patterns that hold you back.

If other therapies and treatments have failed to deliver, ketamine therapy may offer potential to create fundamental changes that deliver profound improvements to your mental health.


What do we treat?

We offer Ketamine-Assisted Therapy for five indications:



The use of psychoactive substances in a way that is harmful or hazardous to health.


Anxiety Disorders

A category of mental health diagnosis that leads to excessive nervousness, fear, and worry.



A mood disorder that may be described as feelings of sadness, loss or helplessness.


Eating Disorders

A group of related conditions including anorexia, bulimia and binge eating. 



An anxiety disorder typically developed after experiencing a traumatic, frightening or distressing event.

Sign Up for Newsletter

Back to top Arrow